{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T22:14:50Z","timestamp":1782339290758,"version":"3.54.5"},"reference-count":156,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["li.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Laboratory Investigation"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.labinv.2024.102185","type":"journal-article","created":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T08:19:53Z","timestamp":1731485993000},"page":"102185","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Switch\/Sucrose Nonfermentable-Deficient Tumors\u2014Morphology, Immunophenotype, Genetics, Epigenetics, Nosology, and Therapy"],"prefix":"10.1016","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0097-5479","authenticated-orcid":false,"given":"Chi Sing","family":"Ng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jilong","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.labinv.2024.102185_bib1","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1038\/s41388-021-01781-x","article-title":"Exploiting vulnerabilities of SWI\/SNF chromatin remodelling complexes for cancer therapy","volume":"40","author":"Wanior","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.labinv.2024.102185_bib2","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s12013-023-01140-5","article-title":"SWI\/SNF chromatin remodelers: structural, functional and mechanistic implications","volume":"81","author":"Singh","year":"2023","journal-title":"Cell Biochem Biophys"},{"key":"10.1016\/j.labinv.2024.102185_bib3","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nrc3068","article-title":"SWI\/SNF nucleosome remodellers and cancer","volume":"11","author":"Wilson","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.labinv.2024.102185_bib4","doi-asserted-by":"crossref","first-page":"8223","DOI":"10.1158\/0008-5472.CAN-09-2166","article-title":"Hijacking the chromatin remodeling machinery: impact of SWI\/SNF perturbations in cancer","volume":"69","author":"Weissman","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.labinv.2024.102185_bib5","doi-asserted-by":"crossref","DOI":"10.1177\/25168657221115656","article-title":"Emerging themes in mechanisms of tumorigenesis by SWI\/SNF subunit mutation","volume":"15","author":"Jones","year":"2022","journal-title":"Epigenet Insights"},{"key":"10.1016\/j.labinv.2024.102185_bib6","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1038\/onc.2009.4","article-title":"The SWI\/SNF complex and cancer","volume":"28","author":"Reisman","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.labinv.2024.102185_bib7","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/370481a0","article-title":"Facilitated binding of TATA-binding protein to nucleosomal DNA","volume":"370","author":"Imbalzano","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.labinv.2024.102185_bib8","doi-asserted-by":"crossref","first-page":"10165","DOI":"10.1073\/pnas.1302209110","article-title":"Swi\/Snf chromatin remodeling\/tumor suppressor complex establishes nucleosome occupancy at target promoters","volume":"110","author":"Tolstorukov","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.labinv.2024.102185_bib9","doi-asserted-by":"crossref","first-page":"5187","DOI":"10.1073\/pnas.0812888106","article-title":"An embryonic stem cell chromatin remodeling complex, esBAF, is an essential component of the core pluripotency transcriptional network","volume":"106","author":"Ho","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.labinv.2024.102185_bib10","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1101\/gr.121145.111","article-title":"Regulation of nucleosome landscape and transcription factor targeting at tissue-specific enhancers by BRG1","volume":"21","author":"Hu","year":"2011","journal-title":"Genome Res"},{"key":"10.1016\/j.labinv.2024.102185_bib11","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nature09692","article-title":"A\u00a0unique chromatin signature uncovers early developmental enhancers in humans","volume":"470","author":"Rada-Iglesias","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.labinv.2024.102185_bib12","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aaz3440","article-title":"ARID1A loss in neuroblastoma promotes the adrenergic-to-mesenchymal transition by regulating enhancer-mediated gene expression","volume":"6","author":"Shi","year":"2020","journal-title":"Sci Adv"},{"key":"10.1016\/j.labinv.2024.102185_bib13","doi-asserted-by":"crossref","first-page":"5139","DOI":"10.1038\/s41467-018-07528-9","article-title":"A\u00a0non-canonical BRD9-containing BAF chromatin remodeling complex regulates naive pluripotency in mouse embryonic stem cells","volume":"9","author":"Gatchalian","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.labinv.2024.102185_bib14","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.neuron.2007.06.019","article-title":"An essential switch in subunit composition of a chromatin remodeling complex during neural development","volume":"5","author":"Lessard","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.labinv.2024.102185_bib15","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/ng.2628","article-title":"Proteomic and bioinformatic analysis of mammalian SWI\/SNF complexes identifies extensive roles in human malignancy","volume":"45","author":"Kadoch","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.labinv.2024.102185_bib16","first-page":"560","article-title":"Loss of BRG1\/BRM in human lung cancer cell lines and primary lung cancers: correlation with poor prognosis","volume":"63","author":"Reisman","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.labinv.2024.102185_bib17","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/00000478-198906000-00001","article-title":"Rhabdoid tumor of kidney. A report of 111 cases from the National Wilms\u2019 Tumor Study Pathology Center","volume":"13","author":"Weeks","year":"1989","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.labinv.2024.102185_bib18","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/(SICI)1098-2264(200005)28:1<31::AID-GCC4>3.0.CO;2-Y","article-title":"Germline INI1 mutation in a patient with a central nervous system atypical teratoid tumor and renal rhabdoid tumor","volume":"28","author":"Biegel","year":"2000","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.labinv.2024.102185_bib19","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S1092-9134(98)80038-5","article-title":"Extrarenal rhabdoid tumors of soft tissue: a clinicopathologic and immunohistochemical study of 18 cases","volume":"2","author":"Fanburg-Smith","year":"1998","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.labinv.2024.102185_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0055119","article-title":"The spectrum of SWI\/SNF mutations, ubiquitous in human cancers","volume":"8","author":"Shain","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.labinv.2024.102185_bib21","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/cas.12065","article-title":"Lung cancer with loss of BRG1\/BRM, shows epithelial mesenchymal transition phenotype and distinct histologic and genetic features","volume":"104","author":"Matsubara","year":"2013","journal-title":"Cancer Sci"},{"key":"10.1016\/j.labinv.2024.102185_bib22","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/path.5836","article-title":"SWI\/SNF-deficient undifferentiated malignancies: where to draw the line\u2020","volume":"256","author":"Tessier-Cloutier","year":"2022","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.labinv.2024.102185_bib23","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1146\/annurev-cancerbio-030617-050151","article-title":"SWI\/SNF (BAF) complexes: guardians of the epigenome","volume":"2","author":"Mathur","year":"2018","journal-title":"Ann Rev Cancer Biol"},{"key":"10.1016\/j.labinv.2024.102185_bib24","first-page":"1418","article-title":"Brg1 modulates enhancer activation in mesoderm lineage commitment","volume":"142","author":"Alexander","year":"2015","journal-title":"Development"},{"key":"10.1016\/j.labinv.2024.102185_bib25","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/ng.3746","article-title":"SMARCB1-mediated SWI\/SNF complex function is essential for enhancer regulation","volume":"49","author":"Wang","year":"2017","journal-title":"Nat Genet"},{"key":"10.1016\/j.labinv.2024.102185_bib26","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S1097-2765(00)80315-9","article-title":"Reconstitution of a core chromatin remodeling complex from SWI\/SNF subunits","volume":"3","author":"Phelan","year":"1999","journal-title":"Mol Cell"},{"key":"10.1016\/j.labinv.2024.102185_bib27","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/s41576-019-0128-0","article-title":"Long-range enhancer-promoter contacts in gene expression control","volume":"20","author":"Schoenfelder","year":"2019","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.labinv.2024.102185_bib28","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s41698-020-0108-z","article-title":"Super-enhancer function and its application in cancer targeted therapy","volume":"4","author":"Tang","year":"2020","journal-title":"NPJ Precis Oncol"},{"key":"10.1016\/j.labinv.2024.102185_bib29","doi-asserted-by":"crossref","first-page":"6486","DOI":"10.1158\/0008-5472.CAN-14-0061","article-title":"BRG1\/SMARCA4 inactivation promotes non-small cell lung cancer aggressiveness by altering chromatin organization","volume":"74","author":"Orvis","year":"2014","journal-title":"Can Res"},{"key":"10.1016\/j.labinv.2024.102185_bib30","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1158\/1078-0432.CCR-13-0280","article-title":"Molecular pathways: SWI\/SNF (BAF) complexes are frequently mutated in cancer--mechanisms and potential therapeutic insights","volume":"20","author":"Wang","year":"2014","journal-title":"Clin Cancer Res"},{"issue":"8","key":"10.1016\/j.labinv.2024.102185_bib31","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/jcmm.17709","article-title":"Advances in the role of SWI\/SNF complexes in tumours","volume":"27","author":"Li","year":"2023","journal-title":"J\u00a0Cell Mol Med"},{"key":"10.1016\/j.labinv.2024.102185_bib32","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41586-021-04246-z","article-title":"Targeting SWI\/SNF ATPases in enhancer-addicted prostate cancer","volume":"601","author":"Xiao","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.labinv.2024.102185_bib33","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41594-022-00880-x","article-title":"Cooperation of chromatin remodeling SWI\/SNF complex and pioneer factor AP-1 shapes 3D enhancer landscapes","volume":"30","author":"Wolf","year":"2023","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.labinv.2024.102185_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.113855","article-title":"SWI\/SNF-dependent genes are defined by their chromatin landscape","volume":"43","author":"Basurto-Cayuela","year":"2024","journal-title":"Cell Rep"},{"key":"10.1016\/j.labinv.2024.102185_bib35","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.cell.2013.03.036","article-title":"Selective inhibition of tumor oncogenes by disruption of super-enhancers","volume":"153","author":"Lov\u00e9n","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.labinv.2024.102185_bib36","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/ng.3744","article-title":"ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice","volume":"49","author":"Mathur","year":"2017","journal-title":"Nat Genet"},{"key":"10.1016\/j.labinv.2024.102185_bib37","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.canlet.2017.04.040","article-title":"Down-regulation of ARID1A is sufficient to initiate neoplastic transformation along with epigenetic reprogramming in non-tumorigenic endometriotic cells","volume":"401","author":"Lakshminarasimhan","year":"2017","journal-title":"Cancer Lett"},{"key":"10.1016\/j.labinv.2024.102185_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108366","article-title":"ARID1A mutations promote p300-dependent endometrial invasion through super-enhancer hyperacetylation","volume":"33","author":"Wilson","year":"2020","journal-title":"Cell Rep"},{"key":"10.1016\/j.labinv.2024.102185_bib39","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.molcel.2017.11.026","article-title":"AP-1 transcription factors and the BAF complex mediate signal-dependent enhancer selection","volume":"68","author":"Vierbuchen","year":"2017","journal-title":"Mol Cell"},{"issue":"4","key":"10.1016\/j.labinv.2024.102185_bib40","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.molcel.2010.05.004","article-title":"Simple combinations of lineage-determining cis-regulatory elements required for macrophage and B cell identities","volume":"38","author":"Heinz","year":"2010","journal-title":"Mol Cell"},{"key":"10.1016\/j.labinv.2024.102185_bib41","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S1097-2765(00)80384-6","article-title":"A\u00a0c\/EBP\u03b2 isoform recruits the SWI\/SNF complex to activate myeloid genes","volume":"4","author":"Kowenz-Leutz","year":"1999","journal-title":"Mol Cell"},{"key":"10.1016\/j.labinv.2024.102185_bib42","doi-asserted-by":"crossref","first-page":"4935","DOI":"10.1093\/emboj\/20.17.4935","article-title":"The chromatin remodeling factor brg-1 interacts with \u03b2-catenin to promote target gene activation","volume":"20","author":"Barker","year":"2001","journal-title":"EMBO J"},{"key":"10.1016\/j.labinv.2024.102185_bib43","doi-asserted-by":"crossref","first-page":"7391","DOI":"10.1038\/sj.onc.1207972","article-title":"Implication of BRG1 and cdk9 in the STAT3-mediated activation of the p21waf1 gene","volume":"23","author":"Giraud","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.labinv.2024.102185_bib44","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.molcel.2018.06.040","article-title":"Binding of TMPRSS2-ERG to BAF chromatin remodeling complexes mediates prostate oncogenesis","volume":"71","author":"Sandoval","year":"2018","journal-title":"Mol Cell"},{"key":"10.1016\/j.labinv.2024.102185_bib45","doi-asserted-by":"crossref","first-page":"337","DOI":"10.18632\/oncoscience.333","article-title":"BRG1 and BRM loss selectively impacts RB and P53, respectively: BRG1 and BRM have differential functions in\u00a0vivo","volume":"3","author":"Marquez-Vilendrer","year":"2016","journal-title":"Oncoscience"},{"key":"10.1016\/j.labinv.2024.102185_bib46","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41586-018-0658-1","article-title":"The SWI\/SNF complex is a mechanoregulated inhibitor of YAP and TAZ","volume":"563","author":"Chang","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.labinv.2024.102185_bib47","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1158\/0008-5472.CAN-20-1417","article-title":"BRD9 is a critical regulator of androgen receptor signaling and prostate cancer progression","volume":"81","author":"Alpsoy","year":"2021","journal-title":"Cancer Res"},{"key":"10.1016\/j.labinv.2024.102185_bib48","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.1111\/jcmm.17418","article-title":"PBRM1 deficiency oncogenic addiction is associated with activated AKT-mTOR signalling and aerobic glycolysis in clear cell renal cell carcinoma cells","volume":"26","author":"Tang","year":"2022","journal-title":"J\u00a0Cell Mol Med"},{"key":"10.1016\/j.labinv.2024.102185_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0184445","article-title":"SWI\/SNF Infobase-An exclusive information portal for SWI\/SNF remodeling complex subunits","volume":"12","author":"Mani","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.labinv.2024.102185_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2023.147420","article-title":"SWI\/SNF complexes and cancers","volume":"870","author":"Wang","year":"2023","journal-title":"Gene"},{"key":"10.1016\/j.labinv.2024.102185_bib51","first-page":"6171","article-title":"BRG1, a component of the SWI-SNF complex, is mutated in multiple human tumor cell lines","volume":"60","author":"Wong","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.labinv.2024.102185_bib52","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/humu.20730","article-title":"Frequent BRG1\/SMARCA4-inactivating mutations in human lung cancer cell lines","volume":"29","author":"Medina","year":"2008","journal-title":"Human Mutat"},{"key":"10.1016\/j.labinv.2024.102185_bib53","doi-asserted-by":"crossref","first-page":"56153","DOI":"10.18632\/oncotarget.10593","article-title":"Mechanism of BRG1 silencing in primary cancers","volume":"7","author":"Marquez-Vilendrer","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.labinv.2024.102185_bib54","doi-asserted-by":"crossref","first-page":"E1999","DOI":"10.1002\/humu.21415","article-title":"Massive parallel DNA pyrosequencing analysis of the tumor suppressor BRG1\/SMARCA4 in lung primary tumors","volume":"32","author":"Rodriguez-Nieto","year":"2011","journal-title":"Hum Mutat"},{"key":"10.1016\/j.labinv.2024.102185_bib55","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.jtho.2020.01.002","article-title":"Clinicopathologic characteristics of BRG1-deficient NSCLC","volume":"15","author":"Daggo-Jack","year":"2020","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.labinv.2024.102185_bib56","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1136\/jcp-2024-209394","article-title":"SMARCA4 alterations in non-small cell lung cancer: a systematic review and meta-analysis","volume":"77","author":"Wankhede","year":"2024","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.labinv.2024.102185_bib57","doi-asserted-by":"crossref","first-page":"5701","DOI":"10.1158\/1078-0432.CCR-20-1825","article-title":"The genomic landscape of SMARCA4 alterations and associations with outcomes in patients with lung cancer","volume":"26","author":"Schoenfeld","year":"2020","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.labinv.2024.102185_bib58","doi-asserted-by":"crossref","first-page":"14171","DOI":"10.1002\/cam4.6083","article-title":"Clinical characteristics and prognostic analysis of SMARCA4-deficient non-small cell lung cancer","volume":"12","author":"Liang","year":"2023","journal-title":"Cancer Med"},{"key":"10.1016\/j.labinv.2024.102185_bib59","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3389\/fonc.2014.00372","article-title":"Beyond mutations: additional mechanisms and implications of SWI\/SNF complex inactivation","volume":"4","author":"Marquez","year":"2015","journal-title":"Front Oncol"},{"key":"10.1016\/j.labinv.2024.102185_bib60","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1093\/hmg\/ddu554","article-title":"Expression inactivation of SMARCA4 by microRNAs in lung tumors","volume":"24","author":"Coira","year":"2015","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.labinv.2024.102185_bib61","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.ejca.2012.09.031","article-title":"High expression of miR-21 and miR-155 predicts recurrence and unfavourable survival in non-small cell lung cancer","volume":"49","author":"Yang","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.labinv.2024.102185_bib62","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrc1840","article-title":"Oncomirs\u2014microRNAs with a role in cancer","volume":"6","author":"Esquela-Kerscher","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.labinv.2024.102185_bib63","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.4161\/cc.7.16.6453","article-title":"MicroRNAs and cancer: an overview","volume":"7","author":"Medina","year":"2008","journal-title":"Cell Cycle"},{"key":"10.1016\/j.labinv.2024.102185_bib64","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/ng.2922","article-title":"Recurrent SMARCA4 mutations in small cell carcinoma of the ovary","volume":"46","author":"Jelinic","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.labinv.2024.102185_bib65","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/path.4633","article-title":"Dual loss of the SWI\/SNF complex ATPases SMARCA4\/BRG1 and SMARCA2\/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic type","volume":"238","author":"Karnezis","year":"2016","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.labinv.2024.102185_bib66","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.path.2018.10.006","article-title":"SWI\/SNF complex deficient soft tissue neoplasms: a pattern-based approach to diagnosis and differential diagnosis","volume":"12","author":"Agaimy","year":"2019","journal-title":"Surg Pathol Clin"},{"key":"10.1016\/j.labinv.2024.102185_bib67","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/PAS.0000000000000554","article-title":"SWI\/SNF complex-deficient undifferentiated\/rhabdoid carcinomas of the gastrointestinal tract: a series of 13 cases highlighting mutually exclusive loss of SMARCA4 and SMARCA2 and frequent co-inactivation of SMARCB1 and SMARCA2","volume":"40","author":"Agaimy","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.labinv.2024.102185_bib68","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/PAS.0000000000000941","article-title":"Undifferentiated endometrial carcinomas show frequent loss of core switch\/sucrose nonfermentable complex proteins","volume":"42","author":"K\u00f6bel","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.labinv.2024.102185_bib69","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/PAS.0000000000001375","article-title":"SMARCA4-deficient uterine sarcoma and undifferentiated endometrial carcinoma are distinct clinicopathologic entities","volume":"44","author":"Kolin","year":"2020","journal-title":"AM J Surg Pathol"},{"key":"10.1016\/j.labinv.2024.102185_bib70","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.5858\/arpa.2021-0001-OA","article-title":"SMARCA4\/BRG1-deficient sinonasal carcinoma. Morphologic spectrum and evolving entity","volume":"146","author":"Kakkar","year":"2022","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.labinv.2024.102185_bib71","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1038\/s41379-022-01152-1","article-title":"Primary cutaneous SMARCA4-deficient undifferentiated malignant neoplasm: first two cases with clinicopathologic and molecular comparison to eight visceral counterparts","volume":"35","author":"Russell-Goldman","year":"2022","journal-title":"Mod Pathol"},{"key":"10.1016\/j.labinv.2024.102185_bib72","series-title":"WHO Classification of Tumours Editorial Board. Thoracic Tumours","first-page":"111","article-title":"Thoracic SMARCA4-deficient undifferentiated tumour","author":"Yoshida","year":"2021"},{"key":"10.1016\/j.labinv.2024.102185_bib73","doi-asserted-by":"crossref","first-page":"7058","DOI":"10.1038\/sj.onc.1210514","article-title":"The reversible epigenetic silencing of BRM: implications for clinical targeted therapy","volume":"26","author":"Glaros","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.labinv.2024.102185_bib74","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/onc.2012.613","article-title":"Identifying targets for the restoration and reactivation of BRM","volume":"33","author":"Kahali","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.labinv.2024.102185_bib75","doi-asserted-by":"crossref","first-page":"6505","DOI":"10.1093\/emboj\/cdg621","article-title":"Growth inhibition by the mammalian SWI-SNF subunit Brm is regulated by acetylation","volume":"22","author":"Bourachot","year":"2003","journal-title":"EMBO J"},{"key":"10.1016\/j.labinv.2024.102185_bib76","doi-asserted-by":"crossref","first-page":"5471","DOI":"10.1038\/sj.onc.1208716","article-title":"The Brm gene suppressed at the post-transcriptional level in various human cell lines is inducible by transient HDAC inhibitor treatment, which exhibits antioncogenic potential","volume":"24","author":"Yamamichi","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.labinv.2024.102185_bib77","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.gene.2018.11.032","article-title":"Inactivation of SMARCA2 by promoter hypermethylation drives lung cancer development","volume":"687","author":"Wu","year":"2019","journal-title":"Gene"},{"key":"10.1016\/j.labinv.2024.102185_bib78","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1158\/0008-5472.CAN-10-2345","article-title":"MicroRNAs miR-199a-5p and -3p target the Brm subunit of SWI\/SNF to generate a double-negative feedback loop in a variety of human cancers","volume":"71","author":"Sakura","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.labinv.2024.102185_bib79","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1265\/ehpm.21-00254","article-title":"SMARCA2 deficiency in NSCLC: a clinicopathologic and immunohistochemical analysis of a large series from a single institution","volume":"27","author":"Sun","year":"2022","journal-title":"Environ Health Prev Med"},{"key":"10.1016\/j.labinv.2024.102185_bib80","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.anndiagpath.2016.10.006","article-title":"SMARCA4 and SMARCA2 deficiency in non-small cell lung cancer: immunohistochemical survey of 316 consecutive specimens","volume":"26","author":"Herpel","year":"2017","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.labinv.2024.102185_bib81","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1097\/PAS.0000000000001879","article-title":"Thoracic SMARCA2-deficient but SMARCA4-preserved tumors with undifferentiated morphology combined with Claudin-4 negativity","volume":"46","author":"Iwakoshi","year":"2022","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.labinv.2024.102185_bib82","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1016\/j.jtho.2021.01.1613","article-title":"SMARCA2 deficiency while preserving SMARCA4 and SMARCB1 in lung neuroendocrine carcinomas","volume":"16","author":"Metovic","year":"2021","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.labinv.2024.102185_bib83","doi-asserted-by":"crossref","first-page":"10727","DOI":"10.1158\/0008-5472.CAN-07-2601","article-title":"Frequent loss of Brm expression in gastric cancer correlates with histologic features and differentiation state","volume":"67","author":"Yamaichi","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.labinv.2024.102185_bib84","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1002\/1097-0142(197805)41:5<1937::AID-CNCR2820410538>3.0.CO;2-U","article-title":"Histopathology and prognosis of Wilms tumors: results from the First National Wilms\u2019 Tumor Study","volume":"41","author":"Beckwith","year":"1978","journal-title":"Cancer"},{"key":"10.1016\/j.labinv.2024.102185_bib85","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/pbc.22922","article-title":"Malignant rhabdoid tumours of the kidney (MRTKs), registered on recent SIOP protocols from 1993 to 2005: a report of the SIOP renal tumour study group","volume":"56","author":"vanden Heuvel-Eibrink","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.labinv.2024.102185_bib86","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/path.2103","article-title":"hSNF5\/INI1-deficient tumours and rhabdoid tumours are convergent but not fully overlapping entities","volume":"211","author":"Bourdeaut","year":"2007","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.labinv.2024.102185_bib87","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.3390\/cancers14153645","article-title":"SMARCB1-deficient cancers: novel molecular insights and therapeutic vulnerabilities","volume":"14","author":"Cooper","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.labinv.2024.102185_bib88","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/1078-0432.CCR-10-1795","article-title":"Frequent hSNF5\/INI1 germline mutations in patients with rhabdoid tumor","volume":"17","author":"Bourdeaut","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.labinv.2024.102185_bib89","article-title":"Chromatin remodeling (SWI\/SNF) complexes, cancer, and response to immunotherapy","volume":"10","author":"Krishnamurthy","year":"2022","journal-title":"J\u00a0Immunother Cancer"},{"key":"10.1016\/j.labinv.2024.102185_bib90","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0222305","article-title":"The genetic alteration spectrum of the SWI\/SNF complex: the oncogenic roles of BRD9 and ACTL6A","volume":"14","author":"Sima","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.labinv.2024.102185_bib91","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00428-021-03032-6","volume":"479","author":"Agaimy","year":"2021","journal-title":"Virchows Arch"},{"key":"10.1016\/j.labinv.2024.102185_bib92","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/pin.12350","article-title":"Frequent loss of the expression of multiple subunits of the SWI\/SNF complex in large cell carcinoma and pleomorphic carcinoma of the lung","volume":"65","author":"Yoshimoto","year":"2015","journal-title":"Pathol Int"},{"key":"10.1016\/j.labinv.2024.102185_bib93","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.pathol.2023.12.414","article-title":"SMARCA4 deficiency and mutations are frequent in large cell lung carcinoma and are prognostically significant","volume":"56","author":"Cheung","year":"2024","journal-title":"Pathology"},{"key":"10.1016\/j.labinv.2024.102185_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.216022","article-title":"SMARCA4: current status and future perspectives in non-small-cell lung carcinoma","volume":"554","author":"Tian","year":"2023","journal-title":"Cancer Lett"},{"key":"10.1016\/j.labinv.2024.102185_bib95","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/modpathol.2017.11","article-title":"Clinicopathological and molecular characterization of SMARCA4-deficient thoracic sarcomas with comparison to potentially related entities","volume":"30","author":"Yoshida","year":"2017","journal-title":"Mod Pathol"},{"key":"10.1016\/j.labinv.2024.102185_bib96","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1038\/ng.3399","article-title":"SMARCA4 inactivation defines a group of undifferentiated thoracic malignancies transcriptionally related to BAF-deficient sarcomas","volume":"47","author":"Le Loarer","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.labinv.2024.102185_bib97","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/415436a","article-title":"Prediction of central nervous system embryonal tumour outcome based on gene expression","volume":"415","author":"Pomeroy","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.labinv.2024.102185_bib98","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/ng.127","article-title":"An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors","volume":"40","author":"Ben-Porath","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.labinv.2024.102185_bib99","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1038\/modpathol.2017.61","article-title":"SMARCA4-deficient thoracic sarcoma: a distinctive clinicopathological entity with undifferentiated rhabdoid morphology and aggressive behavior","volume":"30","author":"Sauter","year":"2017","journal-title":"Mod Pathol"},{"key":"10.1016\/j.labinv.2024.102185_bib100","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/PAS.0000000000001188","article-title":"SMARCA4-deficient thoracic sarcomas: clinicopathologic study of 30 cases with an emphasis on their nosology and differential diagnoses","volume":"43","author":"Perret","year":"2019","journal-title":"AmJ Surg Pathol"},{"key":"10.1016\/j.labinv.2024.102185_bib101","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jtho.2019.10.023","article-title":"SMARCA4-deficient thoracic sarcomatoid tumors represent primarily smoking-related undifferentiated carcinomas rather than primary thoracic sarcomas","volume":"15","author":"Rekhtman","year":"2020","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.labinv.2024.102185_bib102","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/emmm.201200236","article-title":"The tumour suppressor and chromatin-remodelling factor BRG1 antagonizes Myc activity and promotes cell differentiation in human cancer","volume":"4","author":"Romero","year":"2012","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.labinv.2024.102185_bib103","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/path.5889","article-title":"Cellular context determines DNA methylation profiles in SWI\/SNF-deficient cancers of the gynecologic tract","volume":"257","author":"Kommoss","year":"2022","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.labinv.2024.102185_bib104","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1097\/00000478-199410000-00005","article-title":"The clinicopathologic spectrum of putative extrarenal rhabdoid tumors. An analysis of 42 cases studied with immunohistochemistry or electron microscopy","volume":"18","author":"Parham","year":"1994","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.labinv.2024.102185_bib105","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1097\/00000478-199809000-00007","article-title":"Atypical teratoid\/rhabdoid tumor of the central nervous system: a highly malignant tumor of infancy and childhood frequently mistaken for medulloblastoma. A Pediatric Oncology Group study","volume":"22","author":"Burger","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.labinv.2024.102185_bib106","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/modpathol.3800581","article-title":"Absence of expression of SMARCB1\/INI1 in malignant rhabdoid tumors of the central nervous system, kidneys and soft tissue: an immunohistochemical study with implications for diagnosis","volume":"19","author":"Sigauke","year":"2006","journal-title":"Mod Pathol"},{"key":"10.1016\/j.labinv.2024.102185_bib107","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1038\/s41379-022-01148-x","article-title":"The genetic landscape of SMARCB1 alterations in SMARCB1-deficient spectrum of mesenchymal neoplasms","volume":"35","author":"Dermawan","year":"2022","journal-title":"Mod Pathol"},{"key":"10.1016\/j.labinv.2024.102185_bib108","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-92223-x","article-title":"SMARCB1 deletion in atypical teratoid rhabdoid tumors results in human endogenous retrovirus K (HML-2) expression","volume":"11","author":"Doucet-O\u2019Hare","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.labinv.2024.102185_bib109","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/00125480-200007030-00007","article-title":"Malignant rhabdoid tumor: a phenotype? An entity?\u2014A controversy revisited","volume":"7","author":"Ogino","year":"2000","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.labinv.2024.102185_bib110","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/pbc.22831","article-title":"Spectrum of SMARCB1\/INI1 mutations in familial and sporadic rhabdoid tumors","volume":"56","author":"Eaton","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.labinv.2024.102185_bib111","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.586288","article-title":"Rhabdoid tumor predisposition syndrome: from clinical suspicion to general management","volume":"11","author":"Del Baldo","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.labinv.2024.102185_bib112","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.ajhg.2010.01.013","article-title":"Germline nonsense mutation and somatic inactivation of SMARCA4\/BRG1 in a family with rhabdoid tumor predisposition syndrome","volume":"86","author":"Schneppenheim","year":"2010","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.labinv.2024.102185_bib113","doi-asserted-by":"crossref","first-page":"16323","DOI":"10.1002\/cam4.6255","article-title":"Recent insights into the SWI\/SNF complex and the molecular mechanism of hSNF5 deficiency in rhabdoid tumors","volume":"12","author":"Kuwahara","year":"2023","journal-title":"Cancer Med"},{"key":"10.1016\/j.labinv.2024.102185_bib114","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/PAP.0000000000000038","article-title":"The expanding family of SMARCB1(INI1)-deficient neoplasia: implications of phenotypic, biological, and molecular heterogeneity","volume":"21","author":"Agaimy","year":"2014","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.labinv.2024.102185_bib115","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/0046-8177(91)90289-2","article-title":"Rhabdoid tumors of soft tissues: a clinicopathologic study of 26 cases enrolled on the intergroup Rhabdomyosarcoma study","volume":"22","author":"Kodet","year":"1991","journal-title":"Hum Pathol"},{"key":"10.1016\/j.labinv.2024.102185_bib116","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1053\/j.semdp.2016.08.003","article-title":"All things rhabdoid and SMARC: an enigmatic exploration with Dr. Louis P. Dehner","volume":"33","author":"Fuller","year":"2016","journal-title":"Semin Diagn Pathol"},{"key":"10.1016\/j.labinv.2024.102185_bib117","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/1097-0142(19820101)49:1<188::AID-CNCR2820490137>3.0.CO;2-D","article-title":"Small cell carcinoma of the ovary with hypercalcemia: a report of eleven cases","volume":"49","author":"Dickersin","year":"1982","journal-title":"Cancer"},{"key":"10.1016\/j.labinv.2024.102185_bib118","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1097\/00000478-199411000-00004","article-title":"Small cell carcinoma of the ovary, hypercalcemic type. A clinicopathological analysis of 150 cases","volume":"18","author":"Young","year":"1994","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.labinv.2024.102185_bib119","doi-asserted-by":"crossref","first-page":"3908","DOI":"10.1158\/1078-0432.CCR-19-3797","article-title":"Small-cell carcinoma of the ovary, hypercalcemic type-genetics, new treatment targets, and concurrent management guidelines","volume":"26","author":"Tischkowitz","year":"2020","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.labinv.2024.102185_bib120","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2023.100374","article-title":"Dedifferentiated and undifferentiated ovarian carcinoma: an aggressive and molecularly distinct ovarian tumor characterized by frequent SWI\/SNF complex inactivation","volume":"37","author":"Tessier-Cloutier","year":"2024","journal-title":"Mod Pathol"},{"key":"10.1016\/j.labinv.2024.102185_bib121","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1097\/PAS.0000000000000173","article-title":"SMARCB1 (INI1)-negative rhabdoid carcinomas of the gastrointestinal tract: clinicopathologic and molecular study of a highly aggressive variant with literature review","volume":"38","author":"Agaimy","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.labinv.2024.102185_bib122","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/his.14096","article-title":"Loss of Switch\/sucrose non-fermenting complex protein expression in undifferentiated gastrointestinal and pancreatic carcinomas","volume":"77","author":"Tessier-Cloutier","year":"2020","journal-title":"Histopathology"},{"key":"10.1016\/j.labinv.2024.102185_bib123","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1186\/s12957-022-02847-0","article-title":"Clinicopathological and prognostic significance of SWI\/SNF complex subunits in undifferentiated gastric carcinoma","volume":"20","author":"Zhang","year":"2022","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.labinv.2024.102185_bib124","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1097\/PAS.0000000000001836","volume":"46","author":"Chang","year":"2022","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.labinv.2024.102185_bib125","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/PAT.0000000000000270","article-title":"SWI\/SNF complex deficiency and mismatch repair protein expression in undifferentiated and dedifferentiated endometrial carcinoma","volume":"47","author":"Stewart","year":"2015","journal-title":"Pathology"},{"key":"10.1016\/j.labinv.2024.102185_bib126","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.anndiagpath.2015.04.001","article-title":"Pattern of SMARCB1 (INI1) and SMARCA4 (BRG1) in poorly differentiated endometrioid adenocarcinoma of the uterus: analysis of a series with emphasis on a novel SMARCA4-deficient dedifferentiated rhabdoid variant","volume":"19","author":"Strehl","year":"2015","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.labinv.2024.102185_bib127","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/modpathol.2015.155","article-title":"Loss of switch\/sucrose non-fermenting complex protein expression is associated with dedifferentiation in endometrial carcinomas","volume":"29","author":"Karnezis","year":"2016","journal-title":"Mod Pathol"},{"key":"10.1016\/j.labinv.2024.102185_bib128","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/gcc.22922","article-title":"Update on SWI\/SNF-related gynecologic mesenchymal neoplasms: SMARCA4-deficient uterine sarcoma and SMARCB1-deficient vulval neoplasms","volume":"60","author":"Howitt","year":"2020","journal-title":"Genes Chromsomes Cancer"},{"key":"10.1016\/j.labinv.2024.102185_bib129","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1053\/j.semdp.2020.08.003","article-title":"SWI\/SNF-deficient malignancies of the female genital tract","volume":"38","author":"McCluggage","year":"2021","journal-title":"Sem Diagn Pathol"},{"key":"10.1016\/j.labinv.2024.102185_bib130","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/cjp2.188","article-title":"SWI\/SNF-deficiency defines highly aggressive undifferentiated endometrial carcinoma","volume":"7","author":"Tessier-Cloutier","year":"2021","journal-title":"J\u00a0Pathol Clin Res"},{"key":"10.1016\/j.labinv.2024.102185_bib131","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/BF00713281","article-title":"The existence of rhabdoid cells in specified soft tissue sarcomas. Histopathological, ultrastructural and immunohistochemical evidence","volume":"411","author":"Tsuneyoshi","year":"1987","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"key":"10.1016\/j.labinv.2024.102185_bib132","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1097\/00000478-200010000-00002","article-title":"Renal cell carcinoma with rhabdoid features","volume":"24","author":"Gokden","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.labinv.2024.102185_bib133","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s10014-011-0069-6","article-title":"Rapid progression of rhabdoid components of a composite high-grade glioma and rhabdoid tumor in the occipital lobe of an adult","volume":"29","author":"Yamamoto","year":"2012","journal-title":"Brain Tumor Pathol"},{"key":"10.1016\/j.labinv.2024.102185_bib134","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1440-1789.2010.01113.x","article-title":"Pediatric rhabdoid meningioma: a morphological, immunohistochemical, ultrastructural and molecular case study","volume":"31","author":"Buccoliero","year":"2011","journal-title":"Neuropathology"},{"key":"10.1016\/j.labinv.2024.102185_bib135","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/modpathol.3800375","article-title":"INI1 expression is retained in composite rhabdoid tumors, including rhabdoid meningiomas","volume":"18","author":"Perry","year":"2005","journal-title":"Mod Pathol"},{"key":"10.1016\/j.labinv.2024.102185_bib136","doi-asserted-by":"crossref","first-page":"495","DOI":"10.5144\/0256-4947.2013.495","article-title":"sarcomatoid renal cell carcinoma with rhabdoid features","volume":"33","author":"Al-Saidi","year":"2013","journal-title":"Ann Saudi Med"},{"key":"10.1016\/j.labinv.2024.102185_bib137","doi-asserted-by":"crossref","first-page":"5508","DOI":"10.1158\/0008-5472.CAN-12-4593","article-title":"A\u00a0synthetic lethality-based strategy to treat cancers harboring a genetic deficiency in the chromatin remodeling factor BRG1","volume":"73","author":"Oike","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.labinv.2024.102185_bib138","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1093\/annonc\/mdw552","article-title":"Targeting chromatin defects in selected solid tumors based on oncogene addiction, synthetic lethality and epigenetic antagonism","volume":"28","author":"Morel","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.labinv.2024.102185_bib139","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41467-019-08380-1","article-title":"SMARCA4 loss is synthetic lethal with CDK4\/6 inhibition in non-small cell lung cancer","volume":"10","author":"Xue","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.labinv.2024.102185_bib140","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.tig.2014.05.001","article-title":"A\u00a0rationale to target the SWI\/SNF complex for cancer therapy","volume":"30","author":"Hohmann","year":"2014","journal-title":"Trends Genet"},{"key":"10.1016\/j.labinv.2024.102185_bib141","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1073\/pnas.1316793111","article-title":"Functional epigenetics approach identifies BRM\/SMARCA2 as a critical synthetic lethal target in BRG1-dependent cancers","volume":"111","author":"Hoffman","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.labinv.2024.102185_bib142","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1038\/s41598-019-48152-x","article-title":"SMARCA2-deficiency confers sensitivity to targeted inhibition of SMARCA4 in esophageal squamous cell carcinoma cell lines","volume":"9","author":"Ehrenhofer-Wolfer","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.labinv.2024.102185_bib143","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1158\/1535-7163.MCT-16-0678","article-title":"Selective killing of SMARCA2- and SMARCA4-deficient small cell carcinoma of the ovary, hypercalcemic type cells by inhibition of ezh2: in\u00a0vitro and in\u00a0vivo preclinical models","volume":"16","author":"Chan-Penebre","year":"2017","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.labinv.2024.102185_bib144","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1517\/14728222.7.3.453","article-title":"The ATPases: a new family for a family-based drug design approach","volume":"7","author":"Chene","year":"2003","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.labinv.2024.102185_bib145","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12791","article-title":"The roles of mutated SWI\/SNF complexes in the initiation and development of hepatocellular carcinoma and its regulatory effect on the immune system: a review","volume":"53","author":"Hu","year":"2020","journal-title":"Cell Prolif"},{"key":"10.1016\/j.labinv.2024.102185_bib146","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.lungcan.2022.05.001","article-title":"SMARCA4-deficient lung carcinoma is an aggressive tumor highly infiltrated by FOXP3+ cells and neutrophils","volume":"169","author":"Velut","year":"2022","journal-title":"Lung Cancer"},{"key":"10.1016\/j.labinv.2024.102185_bib147","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/emboj.2012.350","article-title":"BRG1-mediated immune tolerance: facilitation of Treg activation and partial independence of chromatin remodelling","volume":"32","author":"Chaiyachati","year":"2013","journal-title":"EMBO J"},{"key":"10.1016\/j.labinv.2024.102185_bib148","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/PAP.0000000000000366","article-title":"SWI\/SNF-deficient malignancies: optimal candidates for immune-oncological therapy?","volume":"30","author":"Agaimy","year":"2023","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.labinv.2024.102185_bib149","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.ccell.2019.10.008","article-title":"Clonally expanded T cells reveal immunogenicity of rhabdoid tumors","volume":"36","author":"Leruste","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.labinv.2024.102185_bib150","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.jtho.2021.03.024","article-title":"SMARCA4 and other SWItch\/sucrose nonfermentable family genomic alterations in NSCLC: clinicopathologic characteristics and outcomes to immune checkpoint inhibition","volume":"16","author":"Alessi","year":"2021","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.labinv.2024.102185_bib151","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1080\/15384047.2021.2011643","article-title":"Pan-cancer analysis of ARID family members as novel biomarkers for immune checkpoint inhibitor therapy","volume":"23","author":"Zhu","year":"2022","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.labinv.2024.102185_bib152","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.ygyno.2021.07.005","article-title":"ARID1A mutation\/ARID1A loss is associated with a high immunogenic profile in clear cell ovarian cancer","volume":"162","author":"Kuroda","year":"2021","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.labinv.2024.102185_bib153","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1001\/jamaoncol.2019.3158","article-title":"Clinical validation of PBRM1 alterations as a marker of immune checkpoint inhibitor response in renal cell carcinoma","volume":"5","author":"Braun","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.labinv.2024.102185_bib154","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41389-020-00296-6","article-title":"Emerging role of SWI\/SNF complex deficiency as a target of immune checkpoint blockade in human cancers","volume":"10","author":"Zhou","year":"2021","journal-title":"Oncogenesis"},{"key":"10.1016\/j.labinv.2024.102185_bib155","doi-asserted-by":"crossref","first-page":"5404","DOI":"10.1038\/s41467-021-25260-9","article-title":"SMARCA4\/2 loss inhibits chemotherapy-induced apoptosis by restricting IP3R3-mediated Ca2+ flux to mitochondria","volume":"12","author":"Xue","year":"2021","journal-title":"Nat Comm"},{"key":"10.1016\/j.labinv.2024.102185_bib156","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1158\/1078-0432.CCR-15-1468","article-title":"SMARCA4\/BRG1 is a novel prognostic biomarker predictive of cisplatin-based chemotherapy outcomes in resected non-small cell lung cancer","volume":"22","author":"Bell","year":"2016","journal-title":"Clin Cancer Res"}],"updated-by":[{"DOI":"10.1016\/j.labinv.2024.102220","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000}}],"container-title":["Laboratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683724018634?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683724018634?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T03:07:41Z","timestamp":1767236861000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0023683724018634"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":156,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S0023683724018634"],"URL":"https:\/\/doi.org\/10.1016\/j.labinv.2024.102185","relation":{},"ISSN":["0023-6837"],"issn-type":[{"value":"0023-6837","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Switch\/Sucrose Nonfermentable-Deficient Tumors\u2014Morphology, Immunophenotype, Genetics, Epigenetics, Nosology, and Therapy","name":"articletitle","label":"Article Title"},{"value":"Laboratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.labinv.2024.102185","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 United States & Canadian Academy of Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102185"}}